Sign in
4

Changes in Ownership

Kalaris Therapeutics, Inc. Filed Acc 0000950170-24-062977

General Counsel sold 420 shares at $0.75 ($315)

From the SEC's structured data for this filing

Trades in this filing

Miller Edward · General Counsel

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2024-05-17 Sale : show line 1 in the form −420 $0.75 $315 220,496 D
Open-market sales · 420 sh · avg $0.75 · $315
Loading xslF345X05/ownership.xml…